Vanguard Personalized Indexing Management
CGTX icon

Vanguard Personalized Indexing Management’s Cognition Therapeutics CGTX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Buy
11,595
+561
+5% +$664 ﹤0.01% 2220
2026
Q1 		$8.38K Buy
+11,034
New +$12.8K ﹤0.01% 2158
2025
Q2 		– Sell
-56,002
Closed -$23.6K – 1961
2025
Q1 		$23.6K Buy
+56,002
New +$32.9K ﹤0.01% 1755

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Personalized Indexing Management's CGTX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Cognition Therapeutics (CGTX) stake by 5.1% in Q2 2026, buying an estimated $664 and bringing the position to 11,595 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

Vanguard Personalized Indexing Management first reported a position in CGTX in Q1 2025 and has held it in 3 quarters since. The position peaked at $23.6K in Q1 2025. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 11,595 shares of Cognition Therapeutics worth $13.3K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 561 Cognition Therapeutics shares in Q2 2026, an estimated $664.
  • Cognition Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2220 holding.
  • Vanguard Personalized Indexing Management first reported a position in Cognition Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • Vanguard Personalized Indexing Management's Cognition Therapeutics position peaked at $23.6K in Q1 2025.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.